Protara Therapeutics Inc. (TARA) will be presenting new data from an interim analysis of its ongoing ADVANCED-2 trial at the 25th Annual Meeting of the Society of Urologic Oncology on December 5, 2024.
ADVANCED-2 is an ongoing phase II trial of the company's drug candidate TARA-002 in patients with non-muscle invasive bladder cancer (NMIBC).
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.